×
Hero Background

Migraine Companies

ID: MRFR/Pharma/1756-HCR
85 Pages
Kinjoll Dey
October 2025

At the forefront of neurological healthcare, Migraine companies specialize in innovative solutions. From research to treatment, these organizations focus on developing therapies that address the complexities of migraines, providing relief for patients. Their commitment lies in advancing migraine care and improving overall neurological well-being.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Migraine Market Research Report - Forecast To 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Migraine Market

Migraine Key Companies

 

Latest Migraine Companies Update



Pfizer acquires Biohaven in 2023 strategic move strengthens Pfizer's presence in the migraine market, particularly with Biohaven's flagship CGRP inhibitor, Nurtec ODT.


Eli Lilly partners with Tonix for nasal spray triptans collaboration expands Lilly's migraine portfolio with Tosymra and Zembrace SymTouch, offering alternative delivery options for patients.


Collaborations between pharmaceutical companies, device manufacturers, and digital health platforms are fostering innovation and driving market growth.


List of Migraine Key Companies in the Market



  • Sanofi SA

  • Abbott Laboratories

  • Teva Pharmaceutical Industries Limited

  • Allergan Plc

  • Pfizer Inc

  • AstraZeneca

  • Johnson & Johnson

  • Endo International Plc

  • GlaxoSmithKline Plc

  • Impax Laboratories.